This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Divine Skin Projects Revenues To Reach $15M In 2012

MIAMI BEACH, Fla., May 16, 2012 /PRNewswire/ -- Divine Skin Inc. (OTCBB: DSKX), a leading developer of personal-care products, announced results for its quarter ending March 31, 2012. Net revenue was $1.98 million, compared to $2.25 million in the same quarter of 2011. Gross margin improved significantly, to more than 50 percent or $1.05 million, comparable to last year's quarterly result of $1.10 million. Net loss for the quarter was $428,000, compared to $192,000 for the first quarter of 2011.

Highlights from the first quarter include

  • Introduction of API System 9 to physicians
  • Two new compounds identified that trigger processes for improved hair growth
  • Spectral.F7 study was completed with 15 volunteers showing a significant global improvement in hair counts and density
  • A new scalable $1.5 million line of credit
  • New distribution by United Natural Foods for the NutraOrigin brand
  • Extensive regulatory compliance in preparation for launch in various overseas markets.
  • Reformulation of the popular Revita shampoo for superior cosmetic benefits while retaining the well-established therapeutic results. 

Divine Skin CEO Daniel Khesin stated, "We are on track to see the kind of explosive growth this year that we have witnessed for last year," he concluded. "In 2012, we are projecting $15 million in revenue. That's more than 50 percent growth over 2011."

"So far this year we have closed new deals for more high-margin products, and we have added several new distribution outlets for all items. Such rapid expansion demands greater marketing and inventory expenditures, but we fully expect these investments to bear fruit in the next few quarters.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs